144 related articles for article (PubMed ID: 15367415)
1. Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas.
Faleiro-Rodrigues C; Macedo-Pinto I; Pereira D; Lopes CS
Ann Oncol; 2004 Oct; 15(10):1535-42. PubMed ID: 15367415
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of E-cadherin in patients with advanced serous ovarian cancer.
Bačić B; Haller H; Mrklić I; Košta V; Čarić A; Tomić S
Arch Gynecol Obstet; 2013 Jun; 287(6):1219-24. PubMed ID: 23269354
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
[TBL] [Abstract][Full Text] [Related]
4. Association of E-cadherin and beta-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas.
Faleiro-Rodrigues C; Macedo-Pinto I; Pereira D; Ferreira VM; Lopes CS
Hum Pathol; 2004 Jun; 35(6):663-9. PubMed ID: 15188131
[TBL] [Abstract][Full Text] [Related]
5. Correlation Between E-cadherin Immunoexpression and Efficacy of First Line Platinum-Based Chemotherapy in Advanced High Grade Serous Ovarian Cancer.
Miše BP; Telesmanić VD; Tomić S; Šundov D; Čapkun V; Vrdoljak E
Pathol Oncol Res; 2015 Apr; 21(2):347-56. PubMed ID: 25108408
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of MAPK, Topo IIα and E-cadherin immunoexpression in ovarian serous carcinomas.
Sundov D; Petric Mise B; Mrklic I; Bacic B; Vrdoljak E; Tomic S
Neoplasma; 2017; 64(2):289-298. PubMed ID: 28052682
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin as a prognostic marker in human serous carcinomas of the ovary: an immunohistochemical analysis.
Dian D; Brüning A; Mylonas I
Arch Gynecol Obstet; 2011 Aug; 284(2):437-43. PubMed ID: 20803206
[TBL] [Abstract][Full Text] [Related]
8. Loss of beta-catenin is associated with poor survival in ovarian carcinomas.
Faleiro-Rodrigues C; Macedo-Pinto I; Pereira D; Lopes CS
Int J Gynecol Pathol; 2004 Oct; 23(4):337-46. PubMed ID: 15381903
[TBL] [Abstract][Full Text] [Related]
9. Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients.
Hosono S; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Kikkawa F
Br J Cancer; 2007 Jan; 96(2):314-20. PubMed ID: 17211477
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and predictive values of E-cadherin for patients of ovarian clear cell adenocarcinoma.
Ho CM; Cheng WF; Lin MC; Chen TC; Huang SH; Liu FS; Chien CC; Yu MH; Wang TY; Hsieh CY
Int J Gynecol Cancer; 2010 Dec; 20(9):1490-7. PubMed ID: 21119364
[TBL] [Abstract][Full Text] [Related]
11. The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma.
Cho D; Park H; Park SH; Kim K; Chung M; Moon W; Kang M; Jang K
J Ovarian Res; 2015 Feb; 8():2. PubMed ID: 25823848
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma.
Shim HS; Yoon BS; Cho NH
Hum Pathol; 2009 May; 40(5):693-8. PubMed ID: 19157508
[TBL] [Abstract][Full Text] [Related]
13. Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases.
Daraï E; Scoazec JY; Walker-Combrouze F; Mlika-Cabanne N; Feldmann G; Madelenat P; Potet F
Hum Pathol; 1997 Aug; 28(8):922-8. PubMed ID: 9269828
[TBL] [Abstract][Full Text] [Related]
14. Expression of CXCR4 indicates poor prognosis in patients with clear cell carcinoma of the ovary.
Sekiya R; Kajiyama H; Sakai K; Umezu T; Mizuno M; Shibata K; Yamamoto E; Fujiwara S; Nagasaka T; Kikkawa F
Hum Pathol; 2012 Jun; 43(6):904-10. PubMed ID: 22169254
[TBL] [Abstract][Full Text] [Related]
15. Actinin-4 expression in ovarian cancer: a novel prognostic indicator independent of clinical stage and histological type.
Yamamoto S; Tsuda H; Honda K; Kita T; Takano M; Tamai S; Inazawa J; Yamada T; Matsubara O
Mod Pathol; 2007 Dec; 20(12):1278-85. PubMed ID: 17873890
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
Voutilainen KA; Anttila MA; Sillanpää SM; Ropponen KM; Saarikoski SV; Juhola MT; Kosma VM
J Clin Pathol; 2006 May; 59(5):460-7. PubMed ID: 16461565
[TBL] [Abstract][Full Text] [Related]
17. Expression and localization of e-cadherin in epithelial ovarian cancer.
Koensgen D; Freitag C; Klaman I; Dahl E; Mustea A; Chekerov R; Braicu I; Lichtenegger W; Sehouli J
Anticancer Res; 2010 Jul; 30(7):2525-30. PubMed ID: 20682978
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
19. The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions.
Davidson B; Holth A; Hellesylt E; Tan TZ; Huang RY; Tropé C; Nesland JM; Thiery JP
Hum Pathol; 2015 Jan; 46(1):1-8. PubMed ID: 25455994
[TBL] [Abstract][Full Text] [Related]
20. Nuclear β-catenin positivity as a predictive marker of long-term survival in advanced epithelial ovarian cancer.
Nagy B; Tóth L; Molnár P; Méhes G; Thurzó L; Póka R; Hernádi Z
Pathol Res Pract; 2017 Aug; 213(8):915-921. PubMed ID: 28651933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]